AI Verdict
RGEN has stronger fundamentals based on our AI analysis.
RGNX vs RGEN Fundamental Comparison
| Metric | RGNX | RGEN |
|---|---|---|
| Revenue | $170.4M | $738.3M |
| Net Income | $-193.9M | $48.9M |
| Net Margin | -113.8% | 6.6% |
| ROE | -188.7% | 2.3% |
| ROA | -42.8% | 1.7% |
| Current Ratio | 2.38x | 8.37x |
| Debt/Equity | 0.00x | 0.26x |
| EPS | $-3.76 | $0.86 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RGNX vs RGEN: Frequently Asked Questions
Is RGNX or RGEN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RGEN has stronger fundamentals. RGNX is rated STRONG SELL (92% confidence) while RGEN is rated HOLD (62% confidence). This is not investment advice.
How does RGNX compare to RGEN fundamentally?
REGENXBIO Inc. has ROE of -188.7% vs REPLIGEN CORP's 2.3%. Net margins are -113.8% vs 6.6% respectively.
Which stock pays higher dividends, RGNX or RGEN?
RGNX has a dividend yield of N/A or no dividend while RGEN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RGNX or RGEN for long term?
For long-term investing, consider that RGNX has STRONG SELL rating with 92% confidence, while RGEN has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RGNX vs RGEN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RGNX vs RGEN, the AI consensus favors RGEN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.